Related Experiment Video
Updated: May 14, 2026
05:31
A Fluorescent Screening Assay for Identifying Modulators of GIRK Channels
Published on: April 24, 2012
Current pharmacogenomic studies on hERG potassium channels
Fa-Zhong He1, Howard L McLeod, Wei Zhang
1Pharmacogenetics Research Institute, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University, Changsha, Hunan 410078, PR China.
Trends in Molecular Medicine
|February 2, 2013
Summary
Genetic variations in the human ether-a-go-go-related gene (hERG) potassium channels impact drug responses. Understanding these hERG gene polymorphisms is key for personalized medicine and safer drug use.
Area of Science:
- Pharmacogenomics
- Molecular Biology
- Cardiovascular Pharmacology
Background:
- Genetic polymorphisms in human ether-a-go-go-related gene (hERG) potassium channels are linked to complex diseases and drug sensitivities.
- Individual hERG genotypes can influence varying sensitivities to drugs and their ability to correct functional deficits caused by mutations.
Purpose of the Study:
- To review current pharmacogenomic studies on hERG potassium channels.
- To provide a reference for developing individualized treatments and evaluating drug safety based on hERG genotypes.
Main Methods:
- Review of existing pharmacogenomic literature focusing on hERG potassium channels.
- Analysis of genotype-specific drug responses and safety profiles.
Main Results:
- Not all hERG blockers cause adverse effects; severe reactions may be genotype-specific.
- Drug efficacy and safety can vary significantly between different populations based on hERG polymorphisms.
Conclusions:
- Detecting KCNH2 (hERG1) polymorphisms is crucial for disease prevention and treatment guidance.
- Individualized treatment strategies and re-evaluation of drug safety are essential, considering hERG pharmacogenomics.
Related Concept Videos
01:24Non-gated Ion Channels
Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:18Patch Clamp
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...